RANDOMIZED TRIAL IN ADVANCED OVARIAN-CANCER COMPARING CISPLATIN AND CARBOPLATIN

被引:146
作者
MANGIONI, C
BOLIS, G
PECORELLI, S
BRAGMAN, K
EPIS, A
FAVALLI, G
GAMBINO, A
LANDONI, F
PRESTI, M
TORRI, W
VASSENA, L
ZANABONI, F
MARSONI, S
机构
[1] MARIO NEGRI INST PHARMACOL RES,VIA ERITREA 62,I-20157 MILAN,ITALY
[2] UNIV MILAN,OSPED S GERARDO,OSTETTR GINECOL CLIN,I-20122 MILAN,ITALY
[3] UNIV MILAN,OSTET GINECOL CLIN 3,I-20122 MILAN,ITALY
[4] UNIV BRESCIA,OSTET GINECOL CLIN,BRESCIA,ITALY
[5] BRISTOL MYERS,PHARMACEUT RES & DEV,BRUSSELS,BELGIUM
关键词
D O I
10.1093/jnci/81.19.1464
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1464 / 1471
页数:8
相关论文
共 32 条
[1]   HIGH-DOSE PLATINUM FOR THE TREATMENT OF REFRACTORY OVARIAN-CANCER [J].
BRUCKNER, HW ;
WALLACH, R ;
COHEN, CJ ;
DEPPE, G ;
KABAKOW, B ;
RATNER, L ;
HOLLAND, JF .
GYNECOLOGIC ONCOLOGY, 1981, 12 (01) :64-67
[2]   EARLY CLINICAL-STUDIES WITH CIS-DIAMMINE-1,1-CYCLOBUTANE DICARBOXYLATE PLATINUM-II [J].
CALVERT, AH ;
HARLAND, SJ ;
NEWELL, DR ;
SIDDIK, ZH ;
JONES, AC ;
MCELWAIN, TJ ;
RAJU, S ;
WILTSHAW, E ;
SMITH, IE ;
BAKER, JM ;
PECKHAM, MJ ;
HARRAP, KR .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (03) :140-147
[3]  
CONTE PF, 1987, P ASCO, V6, P118
[4]  
COX DR, 1972, J R STAT SOC B, V34, P187
[5]  
COX DR, 1970, ANAL BINARY DATA, P18
[6]  
EDMONSON JH, 1988, P AN M AM SOC CLIN, V7, P137
[7]  
EISENHAUER EA, 1986, CANCER TREAT REP, V70, P1195
[8]  
EVANS BD, 1983, CANCER TREAT REP, V67, P997
[9]  
GORE ME, 1987, P ASCO, V6, P117
[10]  
Harrap K.R., 1980, CISPLATIN CURRENT ST, P193, DOI 10.1016/B978-0-12-565050-2.50016-4